Firefly Neuroscience Inc(AIFF) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 25 at 7:59 PM ET (Korea 9/26 08:59)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.62 | Insider Own | 9.23% | Shs Outstand | 15.7M | Perf Week | 59.52% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 14.2M | Perf Month | 97.06% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 10.31% | Short Float | 2.11% | Perf Quarter | 52.27% |
| Income | -0.01B | P/S | 17.52 | EPS this Y | - | Inst Trans | 3.08% | Short Ratio | 0.95 | Perf Half Y | -33.44% |
| Sales | 0.00B | P/B | 2.15 | EPS next 5Y | - | ROA | -59.52% | Short Interest | 0.30M | Perf YTD | 129.71% |
| Book/sh | 0.93 | P/C | 3.42 | EPS past 3/5Y | 59.7% - | ROE | -70.52% | 52W High | -36.19% ($3.15) | Perf Year | -30.45% |
| Cash/sh | 0.59 | P/FCF | - | Sales past 3/5Y | -53.03% -39.34% | ROIC | -64.35% | 52W Low | 225.51% ($0.62) | Perf 3Y | -74.23% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.09% | Gross Margin | 38.47% | Volatility(W/M) | 14.71% 10.28% | Perf 5Y | -97.69% |
| Dividend TTM | - | EV/Sales | 12.39 | Sales Y/Y TTM | 320.33% | Oper. Margin | -494.16% | ATR (14) | 0.16 | Perf 10Y | -65.14% |
| Dividend Ex-Date | - | Quick Ratio | 4.85 | EPS Q/Q | 33.38% | Profit Margin | -524.51% | RSI (14) | 80.35 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.87 | Sales Q/Q | 71.91% | SMA20 | 73.35% ($1.16) | Beta | 0.56 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 77.77% ($1.13) | Rel Volume | 455.53 | Prev Close | $1.19 |
| Employees | 17 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 46.32% ($1.37) | Avg Volume(3M) | 0.32M | Price | $2.01 |
| IPO | 1994/4/6 | Option/Short | No/Yes | Trades | 262620 | Volume | 143,747,229 | Change | 68.91% |
🧠 This is a US-based AI brain analytics company that provides BNA (Brain Network Analytics), an FDA 510(k)-cleared platform that uses AI to analyze EEG and event-related potential (ERP) data to help diagnose neuropsychiatric and neurological conditions such as depression, dementia, and ADHD.
Over the past 1 year, roughly in the middle
36% below its 1-year high.
Traded more than usual That is 45553% of its average volume.
AIFF has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $1,752. Peers typically go for $150.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -97.7%. The S&P 500 did +74% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 10.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
IWC iShares Micro-Cap ETF <0.01% 
VXF Vanguard Extended Market Index ETF <0.01% It ranks #179 of 226 in the industry
Based on market cap of $32M.
CREX#176 Creative Realities Inc $34M PER - 
VTSI#177 VirTra Inc $32M PER - 
JG#178 Aurora Mobile Ltd ADR $32M PER 49.0 AIFF#179 Firefly Neuroscience Inc $32M PER - 
BLIV#180 BeLive Holdings $28M PER - 
FAQ
What kind of company is AIFF?
AIFF belongs to the Technology sector and operates in the Software - Application industry.
What is the market cap of AIFF?
The market cap of AIFF is approximately $32M, ranking 5,140 within its sector.
What is the 52-week high and low for AIFF?
AIFF has recorded a 52-week high of $3.15 and a low of $0.62.
